EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer

Kohei Omatsu, Chyi-Long Lee, Kuan-Gen Huang

Gynecology and Minimally Invasive Therapy · 2025-01 · 14 (1) · 66-71

DOI: 10.4103/gmit.gmit_77_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecology and Minimally Invasive Therapy, online erschienen am 27.02.2025. Verfasst von Kohei Omatsu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taipei, Taiwan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Minimally invasive surgery (MIS) is a limited treatment option for early-stage ovarian cancer. The National Comprehensive Cancer Network ® guidelines that salpingo-oophorectomy should be performed with every effort to keep an encapsulated mass intact during removal. We aimed to investigate whether, if tumor rupture was controlled, patients’ oncological outcomes for Stage I ovarian cancer would not be worse in MIS. An endobag was prepared and used to prevent the ovarian cancer cells from spilling into the peritoneal cavity. We report a recent 10-year clinical outcome of MIS for ovarian cancer by oncological endoscopists in gynecology. Materials and Methods: We retrospectively collected clinical data from an electric chart. Collective clinical data included age, body mass index (BMI), operative time (OT), estimated blood loss (EBL), intraoperative rupture (IR), duration of hospital stay (HS), time from the operation date to the first infusion of chemotherapy (TOFC), disease-free survival (DFS), and overall survival (OS) at 5 years. The data were statistically analyzed using EZR.

Results

The median age, BMI, OT, EBL, IR, HS, TOFC, and DFS were 50 years, 23.9 kg/m 2 , 363 min, 100 mL, 65 (98%) patients, 7 days, 15 days, and 43.4 months, respectively. The OS was 98%. The data were consistent with those from the past 10 years, except for a tendency toward an increasing trend in the proportion of ruptured tumors during surgery.

Conclusion

Tumor rupture within the prepared endobag during MIS did not affect the oncological outcomes of early-stage ovarian cancer.

Schlagwörter

Stichwörter der Autor:innen

Frozen sectionStage I epithelial ovarian cancerminimally invasive surgeryprognosis

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taipei, Taiwan.
  • Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.

Zitieren

APA

Omatsu, K., Lee, C. L., & Huang, K. G. (2025). Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer. Gynecology and Minimally Invasive Therapy, 14(1), 66-71. https://doi.org/10.4103/gmit.gmit_77_24

Vancouver

Omatsu K, Lee CL, Huang KG. Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer. Gynecology and Minimally Invasive Therapy. 2025;14(1):66-71. doi:10.4103/gmit.gmit_77_24

BibTeX
@article{Omatsu2025,
  author = {Omatsu, Kohei and Lee, Chyi-Long and Huang, Kuan-Gen},
  title = {Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer},
  journal = {Gynecology and Minimally Invasive Therapy},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {66--71},
  doi = {10.4103/gmit.gmit_77_24}
}
Kostenlos starten →